HERON THERAPEUTICS, INC. /DE/ (HRTX) › Shares OutstandingHERON THERAPEUTICS, INC. /DE/ (HRTX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2010: 40.14M2011: 200.05M2012: 15.11M2013: 23.57M2014: 29.23M2015: 36.11M2016: 39.4K2017: 64.61M2018: 78.17M2019: 90.30M2020: 91.31M2021: 102.00M2022: 119.15M2023: 150.29M2024: 152.13M2025: 188.31M188.31M2010Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025188.31M+23.8%2024152.13M+1.2%2023150.29M+26.1%2022119.15M+16.8%2021102.00M+11.7%202091.31M+1.1%201990.30M+15.5%201878.17M+21.0%201764.61M+164069.7%201639.4K-99.9%201536.11M+23.5%201429.23M+24.0%201323.57M+56.0%201215.11M-92.4%2011200.05M+398.3%201040.14M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share